Mebhydrolin

CAS : 524-81-2

Ref. 3D-AAA52481

Informations sur le produit

• Nom: Mebhydrolin
• Synonymes: 1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-, 1H-Pyrido[4,3-b]indole, 5-benzyl-2,3,4,5-tetrahydro-2-methyl-, 2,3,4,5-Tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido[4,3-b]indole, 2H-Pyrido[4,3-b]indole, 5-benzyl-1,3,4,5-tetrahydro-2-methyl-, 3-Methyl-9-benzyl-1,2,3,4-tetrahydro-γ-carboline, 5-Benzyl-1,2,3,4-Tetrahydro-2-Methylpyrido(4,3-B)Indole, 5-Benzyl-1,2,3,4-tetrahydro-2-methyl-γ-carboline, 5-Benzyl-1,3,4,5-tetrahydro-2-methyl-2H-pyrido[4,3-b]indole, 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-2-ium, 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole, N-Methyl-9-benzyltetrahydro-γ-carboline, naphthalene-1,5-disulfonic acid - 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (1:1)
• CAS: 524-81-2

Description

Mebhydrolin is a drug used to treat metabolic disorders and symptoms such as hyperglycemia, hyperlipidemia, and hyperuricemia. It is also used for the treatment of autoimmune diseases, such as rheumatoid arthritis. Mebhydrolin inhibits potassium dichromate-induced dopamine release in rat brain synaptosomes. The clinical relevance of this effect is not clear. Mebhydrolin has been shown to have no toxicological effects on the bowel and may be beneficial in bowel disease because it stimulates sodium citrate absorption. In addition, mebhydrolin has been shown to inhibit inflammatory bowel disease by blocking the 5HT3 receptor activity in animal studies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 276.38 g/mol
• Formule: C₁₉H₂₀N₂
• Degré de pureté: Min. 95%